Another important milestone was reached for our recently launched open access journals, Drug Safety-Case Reports and Drugs-Real World Outcomes. Content from these journals is now available on PubMed Central.
The Adis journals portfolio will expand in 2017, with the launch of PharmacoEconomics-Open. This new journal will be fully open access and will focus on the publication of applied research on the economic implications and health outcomes associated with drugs, devices and other healthcare interventions. It joins our other well respected health outcomes publications, PharmacoEconomics, Applied Health Economics and Health Policy and, The Patient: PatientCentered Outcomes Research.
I offer my sincere thanks to all authors who have contributed articles to Molecular Diagnosis & Therapy over the course of 2016. Their skill and dedication are critical to the continued publication of the journal. The quality of published articles is, similarly, testament to the significant efforts of the peer reviewers, whose commitment ensures that the journal's content is held to the highest possible standard. I would like to thank the following individuals who acted as reviewers for Molecular Diagnosis & Therapy in the last 12 months:
